REGENERON PHARMACEUTICALS, INC. Stockholders' Equity 2007-2026 | REGN
What is stockholders' equity?
Stockholders' equity can be defined as total assets minus total liabilities, representing the owners' residual interest in the company after all debts are paid.
What is REGENERON PHARMACEUTICALS, INC.'s current stockholders' equity?
REGENERON PHARMACEUTICALS, INC. (REGN) annual stockholders' equity for 2025 was $31.26B, a 6.48% increase from 2024. REGENERON PHARMACEUTICALS, INC. stockholders' equity for the quarter ending March 31, 2026 was $31.42B.
What was REGENERON PHARMACEUTICALS, INC.'s stockholders' equity in 2024?
REGENERON PHARMACEUTICALS, INC. annual stockholders' equity for 2024 was $29.35B, a 13.02% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s stockholders' equity in 2023?
REGENERON PHARMACEUTICALS, INC. annual stockholders' equity for 2023 was $25.97B, a 14.60% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year stockholders' equity CAGR?
REGENERON PHARMACEUTICALS, INC. stockholders' equity grew at a compound annual growth rate (CAGR) of 23.17% from FY2020 to FY2025, going from $11.03B to $31.26B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $31.26B | +6.5% | 10-K |
| FY2024 | $29.35B | +13.0% | 10-K |
| FY2023 | $25.97B | +14.6% | 10-K |
| FY2022 | $22.66B | +20.8% | 10-K |
| FY2021 | $18.77B | +70.2% | 10-K |
| FY2020 | $11.03B | -0.6% | 10-K |
| FY2019 | $11.09B | +26.6% | 10-K |
| FY2018 | $8.76B | +42.5% | 10-K |
| FY2017 | $6.14B | +38.1% | 10-K |
| FY2016 | $4.45B | +21.7% | 10-K |
| FY2015 | $3.65B | +43.3% | 10-K |
| FY2014 | $2.55B | +29.8% | 10-K |
| FY2013 | $1.96B | +56.3% | 10-K |
| FY2012 | $1.26B | +158.7% | 10-K |
| FY2011 | $485.7M | -8.0% | 10-K |
| FY2010 | $527.8M | +33.0% | 10-K |
| FY2009 | $396.8M | -5.9% | 10-K |
| FY2008 | $421.5M | -8.2% | 10-K |
| FY2007 | $459.3M | - | 10-K |